ETFs positioned on Daiichi Sankyo Company, Limited

Name Weight AuM 1st Jan change
25.16% 28 M€ -8.27% -
4.18% 4 M€ -30.99% -
3.32% 0 M€ -.--% -
3.32% 0 M€ -.--% -
3.24% 14 M€ -1.44% -
2.78% 70 M€ -0.77% -
2.69% 114 M€ +0.27% -
2.19% 14 M€ -0.37% -
2.13% 69 M€ +1.68% -
1.96% 9,871 M€ +1.28% -
1.95% 4,985 M€ +0.86% -
1.78% 0 M€ -.--% -
1.78% 1 M€ +0.60% -
1.71% 22 M€ +8.34% -
1.68% 13,810 M€ -0.22% -
1.64% 27,062 M€ -0.92% -
1.63% 893 M€ -0.84% -
1.42% 64,200 M€ +0.68% -
1.42% 142,231 M€ +0.63% -
1.42% 20,456 M€ +1.68% -
1.35% 17 M€ +1.46% -
1.29% 2 M€ +0.12% -
1.08% 60 M€ +1.24% -
0.99% 60,944 M€ -1.04% -
0.68% 908 M€ +1.61% -
0.44% 28 M€ -0.50% -
0.25% 33,076 M€ +11.21% -
0.25% 9 M€ +14.95% -
0.19% 32 M€ +14.31% -
0.18% 0 M€ -.--% -
Logo Daiichi Sankyo Company, Limited
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Employees
19,765
More about the company
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
3,135.00JPY
Average target price
5,729.41JPY
Spread / Average Target
+82.76%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. ETFs Daiichi Sankyo Company, Limited